Taiyen Biotech Co. Ltd. Statistics
Taiyen Biotech Co. Ltd. (1737) Stock Statistics & Valuation Metrics
Total Valuation
Taiyen Biotech Co. Ltd. has a market cap or net worth of TWD 5.98B. The enterprise value is TWD 4.65B.
- Market Cap
- TWD 5.98B
- Enterprise Value
- TWD 4.65B
Share Statistics
Taiyen Biotech Co. Ltd. has 200,000,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 200,000,000
- Owned by Insiders
- ―
- Owned by Institutions
- 1.85%
Financial Efficiency
Taiyen Biotech Co. Ltd.’s return on equity (ROE) is 0.06 and return on invested capital (ROIC) is 5.06%.
- Return on Equity (ROE)
- 0.06
- Return on Assets (ROA)
- 0.05
- Return on Invested Capital (ROIC)
- 5.06%
- Return on Capital Employed (ROCE)
- 0.07
- Revenue Per Employee
- 6.91M
- Profits Per Employee
- 834.80K
- Employee Count
- 479
- Asset Turnover
- 0.40
- Inventory Turnover
- 5.21
Valuation Ratios
The current PE Ratio of Taiyen Biotech Co. Ltd. is 15.33. Taiyen Biotech Co. Ltd.’s PEG ratio is 1.42.
- PE Ratio
- 15.33
- PS Ratio
- 1.87
- PB Ratio
- 0.89
- Price to FCF
- 21.46
- Price to Operating Cash Flow
- 10.25
- PEG Ratio
- 1.42
Income Statement
In the last 12 months, Taiyen Biotech Co. Ltd. had revenue of 3.31B and earned 399.87M in profits. Earnings per share was 2.00.
- Revenue
- 3.31B
- Gross Profit
- 1.34B
- Operating Income
- 476.14M
- Pretax Income
- 493.97M
- Net Income
- 399.87M
- EBITDA
- 720.11M
- Earnings Per Share (EPS)
- 2.00
Cash Flow
In the last 12 months, operating cash flow was 583.78M and capital expenditures -305.11M, giving a free cash flow of 278.67M billion.
- Operating Cash Flow
- 583.78M
- Free Cash Flow
- 278.67M
- Free Cash Flow per Share
- 1.39
Dividends & Yields
Taiyen Biotech Co. Ltd. pays an annual dividend of ―, resulting in a dividend yield of 4.68%
- Dividend Per Share
- ―
- Dividend Yield
- 4.68%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 4.66%
- Earnings Yield
- 6.51%
Stock Price Statistics
- Beta
- 0.06
- 52-Week Price Change
- -5.83%
- 50-Day Moving Average
- 30.21
- 200-Day Moving Average
- 30.36
- Relative Strength Index (RSI)
- 40.18
- Average Volume (3m)
- 288.55K
Important Dates
Taiyen Biotech Co. Ltd. upcoming earnings date is Mar 15, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 06, 2026
- Next Earnings Date
- Mar 15, 2027
- Ex-Dividend Date
- ―
Financial Position
Taiyen Biotech Co. Ltd. as a current ratio of 2.87, with Debt / Equity ratio of 3.28%
- Current Ratio
- 2.87
- Quick Ratio
- 2.48
- Debt to Market Cap
- 0.03
- Net Debt to EBITDA
- -1.56
- Interest Coverage Ratio
- 140.95
Taxes
In the past 12 months, Taiyen Biotech Co. Ltd. has paid 100.28M in taxes.
- Income Tax
- 100.28M
- Effective Tax Rate
- 0.20
Enterprise Valuation
Taiyen Biotech Co. Ltd. EV to EBITDA ratio is 6.86, with an EV/FCF ratio of 16.65.
- EV to Sales
- 1.45
- EV to EBITDA
- 6.86
- EV to Free Cash Flow
- 16.65
- EV to Operating Cash Flow
- 7.95
Balance Sheet
Taiyen Biotech Co. Ltd. has TWD 1.97B in cash and marketable securities with TWD 228.22M in debt, giving a net cash position of TWD 1.74B billion.
- Cash & Marketable Securities
- TWD 1.97B
- Total Debt
- TWD 228.22M
- Net Cash
- TWD 1.74B
- Net Cash Per Share
- TWD 8.69
- Tangible Book Value Per Share
- TWD 33.45
Margins
Gross margin is 39.05%, with operating margin of 13.50%, and net profit margin of 12.21%.
- Gross Margin
- 39.05%
- Operating Margin
- 13.50%
- Pretax Margin
- 15.06%
- Net Profit Margin
- 12.21%
- EBITDA Margin
- 21.21%
- EBIT Margin
- 13.13%
Analyst Forecast
The average price target for Taiyen Biotech Co. Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -2.24%
- EPS Growth Forecast
- 13.09%
